Illness never sleeps, so neither can we
LEARN MORELatest Updates
VIEW ALL-
Statements & press releases 03.04.20
Europe’s COVID-19 battle: Update on the supply of medicines to the patients that need them
EFPIA member companies are working around the clock to increase capacity and ensure supply of critical medicines to patients across Europe
Read Article -
Blog articles 02.04.20
COVID-19 – A multiplier impact on the diabetes community (Guest blog)
While focusing on immediate priorities and public health emergencies, we should all already start learning from this crisis and derive key imperatives...
Read Article -
Statements & press releases 01.04.20
European research-based industry publishes commitments on tackling COVID-19
With Europe at the epicentre of the COVID-19 crisis, the researched-based pharmaceutical industry is coming together to commit its resources, expertise...
Read Article -
External Events 30.06.20
POSTPONED - DIA Europe 2020
As a direct result of the outbreak of the coronavirus disease (COVID-19), DIA has decided to postpone DIA Europe 2020 in Brussels, to June 30 - July 3,...
View Event -
External Events 23.08.20
11th World Congress on Alternatives and Animal Use in the Life Sciences 2020
The Congress will explore the latest in 3R R&D and will provide a multidisciplinary programme covering more traditional themes as well as very latest issues...
View Event -
External Events 10.09.20
POSTPONED - c4c Multi-Stakeholder Meeting on Child Psychiatry
The first c4c Multi-Stakeholder Meeting on Child Psychiatry seeks to facilitate dialogue and provide an opportunity for constructive interactions among...
View Event
Featured Articles
Featured article
European pharmaceutical industry response to COVID-19
As the impact of COVID-19 continues to be felt across the world, the biopharmaceutical industry in Europe remains committed to global efforts to care for those affected, contain the outbreak and develop resources to tackle future outbreaks.
Read more